CN109637659A - A kind of clinical test initiating method and system for surveying platform certainly for disease - Google Patents
A kind of clinical test initiating method and system for surveying platform certainly for disease Download PDFInfo
- Publication number
- CN109637659A CN109637659A CN201811519688.9A CN201811519688A CN109637659A CN 109637659 A CN109637659 A CN 109637659A CN 201811519688 A CN201811519688 A CN 201811519688A CN 109637659 A CN109637659 A CN 109637659A
- Authority
- CN
- China
- Prior art keywords
- clinical test
- disease
- product
- corporate member
- corporate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Abstract
The present invention provides a kind of clinical test initiating method and system for disease from survey platform, including (1) establishes disease circle from platform is surveyed in disease, and corresponding disease circle establishes corporate member and individual member；(2) corporate member establishes product library, by " clinical test initiation " as one of the product in product library, is issued；(3) individual member selects " clinical test initiation " product, participates in clinical test；(4) individual member is equipped with clinical test demand application function, and the clinical test demand application function is directed to any product of corporate member's publication；(5) after clinical test is initiated, participant submits data feedback.Through the invention, the method and system for establishing clinical test initiation realizes clinical test initiation function from platform is surveyed in disease, carries out clinical test for enterprise and provide new channel, participate in clinical test for sufferer and provide convenient and fast channel.
Description
Technical field
The invention belongs to computerized information fields, especially relate to a kind of clinical test hair for disease from survey platform
Play method and system
Background technique
Quickly, life stress is also very big, this is just that the health of people is brought very for people's lives rhythm at this stage
More secret worries.Once people's health goes wrong, first choice is hospital, but the people seen a doctor in hospital seems eternal right and wrong again
Chang Duo, even some small symptom, the process entirely seen a doctor, which is got off, to be taken a lot of time；And if when people feel to delay
Between, be unwilling hospital, only buys a little medicines according to the experience of oneself and takes, and is possible to miss golden hour again in this way, indulge in
The accidentally state of an illness.
Based on this phenomenon, if it is possible to have one people is helped to carry out disease from the information platform surveyed, it will to people
Huge help is generated, people first can carry out just the sufferer of oneself by the content of information platform, in conjunction with the situation of itself
The judgement of phase, symptom are slight, can be carried out according to the content of information platform self it is simple treat, the dangerous development of symptom
When trend, then go hospitalize.
Have from survey platform, then accordingly from survey platform on functional requirement will be more and more, wherein important
Be from survey platform, there are no the functions of can be realized " clinical test initiation ", this is current urgent problem.
Summary of the invention
The problem to be solved in the present invention is to design a kind of clinical test initiating method and system for disease from survey platform,
To provide the function of clinical test initiation from survey platform.
In order to achieve the above object, the technical scheme adopted by the invention is as follows: it is a kind of for disease from the clinical examination for surveying platform
Test initiating method, comprising:
(1) disease circle is established from platform is surveyed in disease, corresponding disease circle establishes corporate member and individual member；
(2) corporate member establishes product library, by " clinical test initiation " as one of the product in product library, is sent out
Cloth；
(3) individual member selects " clinical test initiation " product, participates in clinical test；
(4) individual member is equipped with clinical test demand application function, and the clinical test demand application function is directed to enterprise
Any product of member's publication；
(5) after clinical test is initiated, participant submits data feedback.
Further, the method for building up of step (1) the disease circle are as follows:
(101) medical information ontology (Medical Ontology) database, i.e. MO database are established；By disease and its spy
Requisition MO terms is numbered；Each MO terms represents a vertex, the relationship directed edge table between two terms
Show, in this way indicates disease and symptom in a directed acyclic graph；
(102) one is created using drug electronic mark code as corresponding MO terms in the storage MO database of key code
Hash table MO hash；
(103) disease circle is created, the parameter of the disease circle includes:
Disease stage locating for sufferer, including just suffer from, it recurs, gentlier, seriously, early period, mid-term, the later period, I, II, the III phase,
With set J={ J1,J2,J3... } and it represents；
The drug products collection M={ M that the corresponding stage uses1,M2,…,Mn, n indicates product number；
And course for the treatment of T={ T is taken/used to corresponding every kind of product1,T2,….,Tn}；
And corresponding every kind of product therapeutic effect E={ E1,E2,….,En}；
And corresponding course for the treatment of drug spends F={ F1,F2,…,Fn}；
And corresponding drug resistance time N={ N1,N2,…,Nn}；
And corresponding adverse reaction time R={ R1,R2,…,Rn}；
And the corresponding treatment information matrix D={ M, T, E, F, N, R } generated according to above- mentioned information；
It further include corporate member's set and individual member's set；The corporate member of corporate member's set and drug products
Collect M association.
Further, in step (2), the product of " the clinical test initiation ", including clinical test title, when progress
Between, number is recruited, hospital doctor, the parameter setting in test period place are participated in.
Further, in the step (3), individual member select " clinical test initiations " product, submit real information with
Contact method.
Further, in the step (5), participant is reminded to mention according to corporate member's setting time node from platform is surveyed
Hand over data feedback；It can also check at any time, data feedback content is clinical test title, is used using drug using the time
Amount, using interval, whether duration of medication takes other drugs or sensitive food, uploads blood count report；It is provided with corporate member
Master pattern compare and analyze.
Another aspect of the present invention additionally provides a kind of clinical test initiation system for disease from survey platform, comprising:
Disease circle module, for establishing disease circle from platform is surveyed in disease, corresponding disease circle establishes corporate member and individual
Member；
Corporate member's module establishes product library for corporate member, by " clinical test initiation " as the production in product library
One of product are issued；
Individual member's module selects " clinical test initiation " product for individual member, participates in clinical test；
Apply for module, is equipped with clinical test demand application function, the clinical test demand application function for individual member
It can be for any product of corporate member's publication；
Feedback module, after initiating for clinical test, participant submits data feedback.
Further, disease circle module establishes disease circle and includes:
(101) medical information ontology (Medical Ontology) database, i.e. MO database are established；By disease and its spy
Requisition MO terms is numbered；Each MO terms represents a vertex, the relationship directed edge table between two terms
Show, in this way indicates disease and symptom in a directed acyclic graph；
(102) one is created using drug electronic mark code as corresponding MO terms in the storage MO database of key code
Hash table MO hash；
(103) disease circle is created, the parameter of the disease circle includes:
Disease stage locating for sufferer, including just suffer from, it recurs, gentlier, seriously, early period, mid-term, the later period, I, II, the III phase,
With set J={ J1,J2,J3... } and it represents；
The drug products collection M={ M that the corresponding stage uses1,M2,…,Mn, n indicates product number；
And course for the treatment of T={ T is taken/used to corresponding every kind of product1,T2,….,Tn}；
And corresponding every kind of product therapeutic effect E={ E1,E2,….,En}；
And corresponding course for the treatment of drug spends F={ F1,F2,…,Fn}；
And corresponding drug resistance time N={ N1,N2,…,Nn}；
And corresponding adverse reaction time R={ R1,R2,…,Rn}；
And the corresponding treatment information matrix D={ M, T, E, F, N, R } generated according to above- mentioned information；
It further include corporate member's set and individual member's set；The corporate member of corporate member's set and drug products
Collect M association.
Further, corporate member's module includes parameter setting unit, for setting the production of " the clinical test initiation "
Product include clinical test title, carry out the time, recruit number, participate in hospital doctor, the parameter setting in test period place.
Further, individual member's module includes submitting unit, selects " clinical test initiation " product for individual member,
Submit real information and contact method.
Further, feedback module includes:
Reminding unit, for reminding participant to submit data anti-according to corporate member's setting time node from survey platform
Feedback；It can also check at any time, data feedback content uses time, usage amount, between use using drug for clinical test title
Every whether duration of medication takes other drugs or sensitive food, uploads blood count report；
Comparison unit, for comparing and analyzing data feedback and the master pattern that corporate member provides.
The invention has the benefit that through the invention, establish the method and system of clinical test initiation, disease from
Surveying platform realizes clinical test initiation function, carries out clinical test for enterprise and provides new channel, participates in for sufferer clinical
Test provides convenient and fast channel.
Specific embodiment
The present invention will be further described combined with specific embodiments below.
In the present invention, specific method includes:
(1) disease circle is established from platform is surveyed in disease, corresponding disease circle establishes corporate member and individual member；
(2) corporate member establishes product library, by " clinical test initiation " as one of the product in product library, is sent out
Cloth；
(3) individual member selects " clinical test initiation " product, participates in clinical test；
(4) individual member is equipped with clinical test demand application function, and the clinical test demand application function is directed to enterprise
Any product of member's publication；
(5) after clinical test is initiated, participant submits data feedback.
Wherein, the method for building up of step (1) the disease circle are as follows:
(101) medical information ontology (Medical Ontology) database, i.e. MO database are established；By disease and its spy
Requisition MO terms is numbered；Each MO terms represents a vertex, the relationship directed edge table between two terms
Show, in this way indicates disease and symptom in a directed acyclic graph；
(102) one is created using drug electronic mark code as corresponding MO terms in the storage MO database of key code
Hash table MO hash；
(103) disease circle is created, the parameter of the disease circle includes:
Disease stage locating for sufferer, including just suffer from, it recurs, gentlier, seriously, early period, mid-term, the later period, I, II, the III phase,
With set J={ J1,J2,J3... } and it represents；
The drug products collection M={ M that the corresponding stage uses1,M2,…,Mn, n indicates product number；
And course for the treatment of T={ T is taken/used to corresponding every kind of product1,T2,….,Tn}；
And corresponding every kind of product therapeutic effect E={ E1,E2,….,En}；
And corresponding course for the treatment of drug spends F={ F1,F2,…,Fn}；
And corresponding drug resistance time N={ N1,N2,…,Nn}；
And corresponding adverse reaction time R={ R1,R2,…,Rn}；
And the corresponding treatment information matrix D={ M, T, E, F, N, R } generated according to above- mentioned information；
It further include corporate member's set and individual member's set；The corporate member of corporate member's set and drug products
Collect M association.
Wherein, in step (2), the product of " the clinical test initiation ", including clinical test title, the time is carried out, is recruited
It raises number, participates in hospital doctor, the parameter setting in test period place.
Wherein, in the step (3), individual member selects " clinical test initiation " product, submits real information and connection
Mode.
Wherein, in the step (5), participant is reminded to submit number according to corporate member's setting time node from platform is surveyed
According to feedback；It can also check at any time, data feedback content is clinical test title, and using drug, using the time, usage amount makes
With interval, whether duration of medication takes other drugs or sensitive food, uploads blood count report；The standard provided with corporate member
Model compares and analyzes.
From in the concrete application for surveying platform, " clinical test initiation " is added in corporate member, is placed on behind product and direct
It is issued in corresponding disease circle, could fill out clinical test title, carry out the time, recruit number, participate in hospital doctor (selection), examination
Test time and location etc..Individual member, which clicks, to be participated in and inputs real information and contact method
Individual member can also initiate clinical test with regard to certain product in disease weight and this hospital is sent to enterprise
During clinical test carries out, platform reminds participant to submit data feedback (integral according to enterprise's setting time node
Button associated quad is not submitted in reward).Enterprise can check that fill substance is clinical test title at any time, using drug, use
Time, usage amount, using interval, whether duration of medication services other drugs or sensitive food etc., uploads blood count report etc.,
For selection), master pattern can be provided with producer compare and analyze
The above is only a specific embodiment of the present invention, is not intended to limit the scope of protection of the present invention, it is all
Within the spirit and principles in the present invention, any modification, equivalent substitution, improvement and etc. done should be included in protection of the invention
Within the scope of.
Claims (10)
1. a kind of clinical test initiating method for surveying platform certainly for disease characterized by comprising
(1) disease circle is established from platform is surveyed in disease, corresponding disease circle establishes corporate member and individual member；
(2) corporate member establishes product library, by " clinical test initiation " as one of the product in product library, is issued；
(3) individual member selects " clinical test initiation " product, participates in clinical test；
(4) individual member is equipped with clinical test demand application function, and the clinical test demand application function is directed to corporate member
Any product of publication；
(5) after clinical test is initiated, participant submits data feedback.
2. the method according to claim 1, wherein the method for building up of step (1) the disease circle are as follows:
(101) medical information ontology (Medical Ontology) database, i.e. MO database are established；Disease and its feature are used
MO terms is numbered；Each MO terms represents a vertex, and the relationship between two terms is indicated with directed edge, this
Sample indicates disease and symptom in a directed acyclic graph；
(102) one is created using drug electronic mark code as the Hash of corresponding MO terms in the storage MO database of key code
Table MO hash；
(103) disease circle is created, the parameter of the disease circle includes:
Disease stage locating for sufferer, including just suffer from, it recurs, gentlier, seriously, early period, mid-term, the later period, I, II, the III phase, with collection
Close J={ J1,J2,J3... } and it represents；
The drug products collection M={ M that the corresponding stage uses1,M2,…,Mn, n indicates product number；
And course for the treatment of T={ T is taken/used to corresponding every kind of product1,T2,….,Tn}；
And corresponding every kind of product therapeutic effect E={ E1,E2,….,En}；
And corresponding course for the treatment of drug spends F={ F1,F2,…,Fn}；
And corresponding drug resistance time N={ N1,N2,…,Nn}；
And corresponding adverse reaction time R={ R1,R2,…,Rn}；
And the corresponding treatment information matrix D={ M, T, E, F, N, R } generated according to above- mentioned information；
It further include corporate member's set and individual member's set；The corporate member and drug products collection M of corporate member's set
Association.
3. the method according to claim 1, wherein in step (2), the product of " the clinical test initiation ",
Including clinical test title, the time is carried out, recruits number, participates in hospital doctor, the parameter setting in test period place.
4. the method according to claim 1, wherein individual member selects " clinical test in the step (3)
Initiate " product, submit real information and contact method.
5. the method according to claim 1, wherein being set from platform is surveyed according to corporate member in the step (5)
Timing intermediate node reminds participant to submit data feedback；It can also check at any time, data feedback content is clinical test title,
Using drug, using time, usage amount, using interval, whether duration of medication takes other drugs or sensitive food, and upload is tested
Blood report；The master pattern provided with corporate member compares and analyzes.
6. a kind of initiate system from the clinical test for surveying platform for disease characterized by comprising
Disease circle module, for establishing disease circle from platform is surveyed in disease, corresponding disease circle establishes corporate member and individual member；
Corporate member's module establishes product library for corporate member, by " clinical test initiation " as the product in product library it
One, it is issued；
Individual member's module selects " clinical test initiation " product for individual member, participates in clinical test；
Apply for module, is equipped with clinical test demand application function, the clinical test demand application function needle for individual member
To any product of corporate member's publication；
Feedback module, after initiating for clinical test, participant submits data feedback.
7. system according to claim 6, which is characterized in that disease circle module establishes disease circle and includes:
(101) medical information ontology (Medical Ontology) database, i.e. MO database are established；Disease and its feature are used
MO terms is numbered；Each MO terms represents a vertex, and the relationship between two terms is indicated with directed edge, this
Sample indicates disease and symptom in a directed acyclic graph；
(102) one is created using drug electronic mark code as the Hash of corresponding MO terms in the storage MO database of key code
Table MO hash；
(103) disease circle is created, the parameter of the disease circle includes:
Disease stage locating for sufferer, including just suffer from, it recurs, gentlier, seriously, early period, mid-term, the later period, I, II, the III phase, with collection
Close J={ J1,J2,J3... } and it represents；
The drug products collection M={ M that the corresponding stage uses1,M2,…,Mn, n indicates product number；
And course for the treatment of T={ T is taken/used to corresponding every kind of product1,T2,….,Tn}；
And corresponding every kind of product therapeutic effect E={ E1,E2,….,En}；
And corresponding course for the treatment of drug spends F={ F1,F2,…,Fn}；
And corresponding drug resistance time N={ N1,N2,…,Nn}；
And corresponding adverse reaction time R={ R1,R2,…,Rn}；
And the corresponding treatment information matrix D={ M, T, E, F, N, R } generated according to above- mentioned information；
It further include corporate member's set and individual member's set；The corporate member and drug products collection M of corporate member's set
Association.
8. system according to claim 6, which is characterized in that corporate member's module includes parameter setting unit, for setting
The product of fixed " the clinical test initiation " includes clinical test title, carries out the time, recruits number, participates in hospital doctor,
The parameter setting in test period place.
9. system according to claim 6, which is characterized in that individual member's module includes submitting unit, for personal meeting
Member's selection " clinical test initiation " product, submits real information and contact method.
10. system according to claim 6, which is characterized in that feedback module includes:
Reminding unit, for reminding participant to submit data feedback according to corporate member's setting time node from survey platform；?
It can check at any time, data feedback content is clinical test title, and using drug, using the time, usage amount uses interval, clothes
Other drugs or sensitive food whether are taken during medicine, upload blood count report；
Comparison unit, for comparing and analyzing data feedback and the master pattern that corporate member provides.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811519688.9A CN109637659A (en) | 2018-12-12 | 2018-12-12 | A kind of clinical test initiating method and system for surveying platform certainly for disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811519688.9A CN109637659A (en) | 2018-12-12 | 2018-12-12 | A kind of clinical test initiating method and system for surveying platform certainly for disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109637659A true CN109637659A (en) | 2019-04-16 |
Family
ID=66073141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811519688.9A Pending CN109637659A (en) | 2018-12-12 | 2018-12-12 | A kind of clinical test initiating method and system for surveying platform certainly for disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109637659A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102955885A (en) * | 2011-08-18 | 2013-03-06 | 张文强 | SOA (service oriented architecture) based test grouping and interview dispensing dynamic random access memory technology |
| CN104484844A (en) * | 2014-12-30 | 2015-04-01 | 天津迈沃医药技术有限公司 | Self-diagnosis method based on disease circle data information |
| CN107247864A (en) * | 2017-04-18 | 2017-10-13 | 上海交通大学附属第六人民医院 | Clinical drug trials and subject's management system and method |
| CN108877904A (en) * | 2018-06-06 | 2018-11-23 | 天津阿贝斯努科技有限公司 | A kind of clinical trial information's cloud platform and clinical trial information's cloud management method |
-
2018
- 2018-12-12 CN CN201811519688.9A patent/CN109637659A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102955885A (en) * | 2011-08-18 | 2013-03-06 | 张文强 | SOA (service oriented architecture) based test grouping and interview dispensing dynamic random access memory technology |
| CN104484844A (en) * | 2014-12-30 | 2015-04-01 | 天津迈沃医药技术有限公司 | Self-diagnosis method based on disease circle data information |
| CN107247864A (en) * | 2017-04-18 | 2017-10-13 | 上海交通大学附属第六人民医院 | Clinical drug trials and subject's management system and method |
| CN108877904A (en) * | 2018-06-06 | 2018-11-23 | 天津阿贝斯努科技有限公司 | A kind of clinical trial information's cloud platform and clinical trial information's cloud management method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wechsler et al. | Active albuterol or placebo, sham acupuncture, or no intervention in asthma | |
| Roberts et al. | Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials | |
| Passman et al. | Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study | |
| Volkow et al. | Is methylphenidate like cocaine?: Studies on their pharmacokinetics and distribution in the human brain | |
| Liu et al. | The effectiveness of a wearable activity tracker (WAT)-based intervention to improve physical activity levels in sedentary older adults: a systematic review and meta-analysis | |
| Yeh et al. | Tai chi exercise in patients with chronic heart failure: a randomized clinical trial | |
| Johnson et al. | An investigation into the analgesic effects of interferential currents and transcutaneous electrical nerve stimulation on experimentally induced ischemic pain in otherwise pain-free volunteers | |
| CN107430641A (en) | Patient care system | |
| Tanay et al. | A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms | |
| Breckon et al. | Physical activity counseling content and competency: a systematic review | |
| Gal et al. | Exercise programs for LVAD supported patients: a snapshot from the ESC affiliated countries | |
| Henderson et al. | A Rasch model analysis of evidence-based treatment practices used in the criminal justice system | |
| Baruth et al. | Psychosocial mediators of physical activity and fitness changes in the activity counseling trial | |
| Zeng et al. | Effectiveness and safety of exercise training and rehabilitation in pulmonary hypertension: a systematic review and meta-analysis | |
| Wong et al. | Peer educator vs. respiratory therapist support: which form of support better maintains health and functional outcomes following pulmonary rehabilitation? | |
| Chen et al. | A systematic review and meta-analysis of the effects of early mobilization therapy in patients after cardiac surgery | |
| Califf et al. | Principles from clinical trials relevant to clinical practice: Part II | |
| Chair et al. | A systematic review of effects of recorded music listening during exercise on physical activity adherence and health outcomes in patients with coronary heart disease | |
| Pinto et al. | Mediators of exercise maintenance after cardiac rehabilitation | |
| CN109637659A (en) | A kind of clinical test initiating method and system for surveying platform certainly for disease | |
| Killey et al. | Effectiveness of interventions for optimising adherence to treatments for the prevention and management of scars: A systematic review | |
| Rozenberg et al. | Feasibility of a Home-Based Exercise Program for Managing Posttransplant Metabolic Syndrome in Lung and Liver Transplant Recipients: Protocol for a Pilot Randomized Controlled Trial | |
| Roth et al. | The “telepress” system for self-measurement and monitoring of blood pressure (the “Shahal” experience in Israel) | |
| Hirt et al. | Nurse-led physical activity interventions for people with dementia in nursing homes: A systematic review on intervention characteristics and implementation facilitators/barriers | |
| Abboudi et al. | Pharmacy-driven performance improvement initiative to increase compliance with intravenous smart pump drug error reduction systems at a large urban academic medical center |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190416 |